ARCHIVES

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

This article is from The Cancer Letter archive.

Vol. 03 No. 43 | October 28, 1977

Download PDF Visit The Full Archive

Related Articles

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011